Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1
1 other identifier
interventional
12
1 country
1
Brief Summary
20 women with myotonic dystrophy type 1 (DM1) will complete a 12-week lower-limb strength training program. The training program consist of 3 series of 6 to 8 maximal repetitions of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. Training sessions will be closely supervise and take place twice a week. It is hypothesize that the training program will induce muscular hypertrophy despite the genetic defect. The training program should also have positive effects on function. The participants will be evaluated at baseline, week 6, week 12, month 6 and month 9 to quantify the effects of the training program and if these effects will be maintained over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 24, 2022
CompletedFirst Posted
Study publicly available on registry
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2023
CompletedFebruary 10, 2023
February 1, 2023
6 months
May 24, 2022
February 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in maximal isometric muscle strength of the knee extensors
Changes in maximal isometric muscle strength of the knee extensors measure by quantify muscle testing using a handheld dynamometer
At baseline, week 6, week 12, month 3 and month 6
Secondary Outcomes (37)
Changes in maximal isometric muscle strength of the knee flexors
At baseline and week 12
Changes in maximal isometric muscle strength of the hip flexors
At baseline and week 12
Changes in maximal isometric muscle strength of the hip extensors
At baseline and week 12
Changes in maximal isometric muscle strength of the hip abductors
At baseline and week 12
Changes in maximal isometric muscle strength of the ankle dorsiflexors
At baseline and week 12
- +32 more secondary outcomes
Study Arms (1)
Training program
EXPERIMENTAL12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises will be perform between 6 and 8 maximal repetitions.
Interventions
12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises will be perform between 6 and 8 maximal repetitions.
Eligibility Criteria
You may qualify if:
- DM1 diagnosis must be confirmed by genetic analysis;
- Women sex, aged between 30 and 65 years old;
- Be able to walk without assistance;
- Consent of the neurologist must be given to participate in this study;
- Must reside in the Saguenay-Lac-St-Jean region;
- Subjects must be able to give their consent freely and voluntarily.
You may not qualify if:
- Patients with any other form of muscular dystrophy are excluded;
- Any contraindication for strenuous exercise or muscle biopsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Université de Sherbrookelead
- Rare Disease Foundationcollaborator
Study Sites (1)
Groupe de recherche interdisciplinaire sur les maladies neuromusculaires
Saguenay, Quebec, G7X 7X2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elise Duchesne, Ph.D
Université du Québec à Chicoutimi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Most outcomes will not be mask, however the outcome assessor will be mask for all muscle biopsy analysis: while analysing the muscle biopsy outcomes, the outcome assessor will not know if it was from baseline or from after the training program.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Investigator
Study Record Dates
First Submitted
May 24, 2022
First Posted
June 1, 2022
Study Start
January 1, 2022
Primary Completion
June 30, 2022
Study Completion
January 10, 2023
Last Updated
February 10, 2023
Record last verified: 2023-02